Quantifying Uncertainty in Alzheimer's Disease Progression Modelling: A Variational Disease Progression Score Framework
TL;DR
A variational Disease Progression Score (DPS) framework is introduced that maps multimodal biomarker dynamics onto a continuous latent timeline with quantified uncertainty, offering a probabilistic foundation for patient-level prognosis and precision monitoring in Alzheimer's disease.
Abstract
Predicting the course of Alzheimer's disease for individual patients remains a major challenge due to the heterogeneity of disease expression and the sparsity of longitudinal data. We introduce a variational Disease Progression Score (DPS) framework that maps multimodal biomarker dynamics (Cerebrospinal fluid, neuroimaging, and cognitive assessments) onto a continuous latent timeline with quantified uncertainty. The framework combines a neural encoder, which infers subject-specific progression parameters from demographic and clinical features, with a cascade of logistic functions structured according to the amyloid cascade hypothesis. Applied to the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort, the inferred timeline separated diagnostic groups it never observed (AUC 0.98 for cognitively normal vs Alzheimer's Disease), and the estimated cascade strengths and biomarker orderings were consistent with the established sequence of Alzheimer's pathology. The model produces individualised prognoses for previously unseen subjects from baseline data alone, with 95% credible intervals achieving 89-98% empirical coverage across biomarkers, and these predictions can be dynamically refined as new observations become available. The framework thus provides a biologically interpretable, uncertainty-aware index of disease severity, offering a probabilistic foundation for patient-level prognosis and precision monitoring in Alzheimer's disease.